SGLT2 inhibitor (class)
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for SGLT2 inhibitor (class), covering 2024-11-27 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial [Phase 2]